Hybridoma
Hybridoma
Hybridoma (/haɪˈbrɪdəmə/) is a cell hybrid resulting from the fusion of a B cell and a myeloma cell. The term is derived from the words "hybrid" and "myeloma".
Etymology
The term "hybridoma" is a portmanteau of "hybrid" and "myeloma". "Hybrid" is derived from the Latin hybrida, meaning the offspring of two different species, and "myeloma" is derived from the Greek words myelos (marrow) and -oma (tumor).
Function
Hybridomas are used in the production of monoclonal antibodies. The B cell provides the ability to produce a specific antibody, while the myeloma cell provides longevity and the ability to proliferate indefinitely. This combination allows for the production of large quantities of a single type of antibody.
Related Terms
- Monoclonal Antibodies: Antibodies that are identical because they were produced by one type of immune cell, all clones of a single parent cell.
- B Cell: A type of white blood cell of the lymphocyte subtype.
- Myeloma Cell: A cancer cell that originates in the plasma cells in the bone marrow.
- Antibody: A blood protein produced in response to and counteracting a specific antigen.
See Also
External links
- Medical encyclopedia article on Hybridoma
- Wikipedia's article - Hybridoma
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski